
Anna Lembke
PersonHeard on podcasts recently
Dr. Anna Lembke is a professor of psychiatry at Stanford University School of Medicine and chief of the Stanford Addiction Medicine Dual Diagnosis Clinic. A world-leading expert on the neuroscience of addiction, she is the author of the best-selling books "Dopamine Nation" and "Drug Dealer, MD."
Rank this week
—
Not in this week’s list
Share of the conversation
—
Reach this week
—
Tone this week
—
Not enough signal yet (fewer than 3 episodes scored).
Share of the conversation
Mentions of Anna Lembke per 1,000 mentions of anything, 7-day rolling, all podcasts.
Show the data
| Day | Share (7-day) | Mentions |
|---|---|---|
| Aug 27 | 0.12‰ | 6 |
| Sep 14 | 0.02‰ | 2 |
| Oct 12 | 0.01‰ | 1 |
| Oct 24 | 0.02‰ | 2 |
| Nov 2 | 0.02‰ | 2 |
| Nov 3 | 0.05‰ | 4 |
| Nov 6 | 0.06‰ | 1 |
| Nov 9 | 0.10‰ | 7 |
| Nov 16 | 0.02‰ | 2 |
| Nov 18 | 0.02‰ | 1 |
What Anna Lembke talks about
The subjects of Anna Lembke's verified claims in the last 90 days.
- Ketamine2 claims
“ketamine is FDA approved for the treatment of treatment-refractory depression.”
Huberman Lab · Nov 9 ↗ - GLP-1 receptor agonist2 claims
“some of those patients, when we put them on a GLP-1, they get into recovery when nothing else works.”
Huberman Lab · Nov 9 ↗ - hallucinogen use2 claims
“as use goes up, the number of ED-related harms and hospital admission-related harms also goes up.”
Huberman Lab · Nov 9 ↗
44 more with Pro.
Discussed alongside
Names that come up in the same conversations as Anna Lembke.
Embed this
Paste this on your site to show Anna Lembke's current trend:
<iframe src="https://podlume.ai/embed/e/anna-lembke" width="360" height="220" style="border:0" loading="lazy" title="Anna Lembke on PodLume Trends"></iframe>